| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8447463 | European Journal of Cancer | 2011 | 9 Pages |
Abstract
This national study based on a strategy including a particular tandem HDCT regimen showed no benefit for previously irradiated patients with relapsed StPNET and very limited benefit for patients with relapsed medulloblastoma.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Barry Pizer, Paul H.J. Donachie, Kathryn Robinson, Roger E. Taylor, Antony Michalski, Jonathan Punt, David W. Ellison, Susan Picton,